Skip to main content
Clinical Trials/NCT03219034
NCT03219034
Completed
Not Applicable

Mid-line Traction Versus Bilateral Thrust Oral Appliances: A Trial to Determine Superiority for Improving Upper Airway Function and Sleep Quality

Texas A&M University1 site in 1 country62 target enrollmentStarted: October 10, 2017Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
62
Locations
1
Primary Endpoint
Respiratory Event Index (REI) at T2

Overview

Brief Summary

This study will compare the effectiveness of the two leading oral appliances (OAs) designs for the treatment of severe obstructive sleep apnea in overweight adults. The effectiveness of OAs has come under question since different designs are combined in evaluating treatment efficacy, for example when comparing them to continuous positive airway pressure Due to the wide range of reported efficacy (53 to 90%), it is of great value to identify the most effective design to guide sleep practitioners and patients.

Detailed Description

The two prominent oral appliances used in treating obstructive sleep apnea differ in their designs, mid-line traction versus bilateral thrust. From a clinical perspective, it is important to know which design is superior and should be the 'treatment of choice' for improving airway function and sleep quality. These two designs differ in their protrusive mechanisms that are categorized in general under four main types: bilateral compression, bilateral thrust, midline compression and mid-line traction. Although the two designs considered in this proposal have undergone the most rigorous testing individually, well controlled 'head-to-head' trials as proposed here have not been conducted to determine their efficacy within a single test population.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • OSA PSG or PG diagnosed adults within 1 year
  • Currently treated with continuous positive airway pressure (CPAP)
  • AHI ≥ \>30 events/hour of sleep
  • Two or more OSA symptoms (snoring, witnessed apnea or daytime hypersomnolence complaint)
  • At least 8 teeth per arch to support either OA device
  • Central and mixed apnea index \<5 events/hour
  • Mallampati score from I to III
  • Palatine tonsils - grade 0, 1, or 2
  • Consent to study's timeline
  • Willingness to wear home sleep test apparatus for at least 4 nights

Exclusion Criteria

  • Cardiac \& pulmonary disease (e.g., congestive heart failure, severe arrhythmias, COPD);
  • Central sleep apnea;
  • Comorbidities with other sleep disorders
  • No active TMD or jaw muscle pain
  • Morphological airway abnormalities
  • Pre-existing difficulty swallowing; throat or neck related health issues
  • Endocrine dysfunction
  • Severe psychiatric disorders;
  • Previous OA therapy; ENT surgery
  • Restrictions in jaw opening

Outcomes

Primary Outcomes

Respiratory Event Index (REI) at T2

Time Frame: 4 weeks

Number of apneas and hypopneas (respiratory events) per hour of recording; REI was reported instead of AHI, as it is a more appropriate measure for home sleep testing.

Secondary Outcomes

  • Stable Sleep Percent(4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Emet D. Schneiderman, PhD

Professor Dr.

Texas A&M University

Study Sites (1)

Loading locations...

Similar Trials